Creating an Innovative Artificial Intelligence–Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial

BACKGROUND: Cancer continues to be the leading cause of mortality in high-income countries, necessitating the development of more precise and effective treatment modalities. Immunotherapy, specifically adoptive cell transfer of T cell receptor (TCR)-engineered T cells (TCR-T therapy), has shown prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Bujak, Joanna, Kłęk, Stanisław, Balawejder, Martyna, Kociniak, Aleksandra, Wilkus, Kinga, Szatanek, Rafał, Orzeszko, Zofia, Welanyk, Joanna, Torbicz, Grzegorz, Jęckowski, Mateusz, Kucharczyk, Tomasz, Wohadlo, Łukasz, Borys, Maciej, Stadnik, Honorata, Wysocki, Michał, Kayser, Magdalena, Słomka, Marta Ewa, Kosmowska, Anna, Horbacka, Karolina, Gach, Tomasz, Markowska, Beata, Kowalczyk, Tomasz, Karoń, Jacek, Karczewski, Marek, Szura, Mirosław, Sanecka-Duin, Anna, Blum, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375398/
https://www.ncbi.nlm.nih.gov/pubmed/37440307
http://dx.doi.org/10.2196/45872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375398/
https://www.ncbi.nlm.nih.gov/pubmed/37440307
http://dx.doi.org/10.2196/45872

Ejemplares similares